The 12 closest competitors and alternatives to CSA Medical Inc among medical devices companies — ranked by similarity to what CSA Medical Inc actually does, not by market-cap band.
Subscribe to see CSA Medical Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
CSA Medical Inc is a medical device company that develops the RejuvenAir System, a cryosurgical device designed to treat chronic bronchitis and chronic obstructive pulmonary disease (COPD). The system uses liquid nitrogen spray in a minimally invasive procedure to destroy diseased cells in the airways, allowing healthy cells to regenerate.
CSA Medical Inc is a medical devices company headquartered in United States. It has raised at least $160.4M across the 10 funding rounds on record. Its most recent funding round raised $2.9M in June 2026. Xcout tracks 8 named people at CSA Medical Inc, including Wendelin Maners (President).
2 more named people on record for CSA Medical Inc, with roles, board committees and tenure — see the full roster →
At least $160.4M raised across the 10 rounds on record. The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.9M | — | |
| Series D | $59.7M | 7 named | |
| SEC Form D filing | $45.2M | — | |
| SEC Form D filing | $5.1M | — | |
| SEC Form D filing | $4.2M | — | |
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to CSA Medical Inc by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical Device
ALung Technologies develops extracorporeal respiratory support devices, including the Hemolung Respiratory Assist System, designed to remove carbon dioxide from blood and support patients with acute respiratory failure. Its products are intended for hospitals and critical-care clinicians treating patients who need respiratory support, including certain patients with severe COPD or who may otherwise require mechanical ventilation.
Similar medical devices company
Noah Medical is a medical technology company that develops robotic-assisted platforms for bronchoscopic procedures. Its Galaxy System is designed to help pulmonologists and other clinicians navigate the lungs and obtain tissue samples for diagnosing suspected lung cancer and other pulmonary conditions.
Similar medical devices company
Lunair Medical is developing an implantable neurostimulation device and connected digital platform designed to treat moderate-to-severe sleep apnea. The system utilizes closed-loop phrenic nerve stimulation and respiration sensing to maintain an open airway during sleep without the use of masks or wearables.
Medical Equipment Manufacturing
CAIRE Health Holdings, Inc. manufactures and supplies medical oxygen therapy equipment, including portable and stationary oxygen concentrators, liquid oxygen systems, and onsite gas generators. The company also provides cardiorespiratory diagnostics devices to healthcare providers, patients, and commercial applications.
Similar medical devices company
Pulmonx Corporation is a biomedical technology firm dedicated to developing and commercializing advanced, less invasive devices for managing chronic obstructive pulmonary diseases. Its primary offering, the Zephyr Endobronchial Valve, is specifically engineered to treat bronchoscopic hyperinflation in adults afflicted with severe emphysema. Complementing its therapeutic solutions, the company also provides the Chartis Pulmonary Assessment System. This system features a specialized balloon catheter and console, fitted with flow and pressure sensors, which is instrumental in evaluating the presence of collateral ventilation in patients. Additionally, Pulmonx offers the StratX Lung Analysis Platform, a cloud-based service that conducts quantitative computed tomography (CT) analysis. This platform delivers vital data concerning emphysema destruction, fissure completeness, and lobar volume, thereby aiding clinicians in accurately identifying the most suitable target lobes for treatment with Zephyr Valves. Pulmonx serves emphysema patients across a broad international footprint, encompassing the United States, Europe, the Middle East, Africa, and the Asia-Pacific region. The company, which changed its name from Pulmonx to Pulmonx Corporation in December 2013, was originally incorporated in 1995 and maintains its corporate headquarters in Redwood City, California.
Similar medical devices company
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
Medical Devices & Aesthetics
CellSound Aesthetics manufactures and sells non-invasive aesthetic devices for face, body, and skin rejuvenation treatments. The company's technology targets fat reduction, loose skin, cellulite, and wrinkles for patients, while providing medical and aesthetic practices with equipment and business solutions.
Similar medical devices company
NIOX Group Plc is a worldwide company dedicated to innovating, developing, and distributing medical devices that measure fractional exhaled nitric oxide (FeNO). A key product is the NIOX VERO system, an easily portable and non-invasive diagnostic tool designed for immediate, on-site patient use. This system includes a compact device alongside a suite of disposable items like sensors, individual mouthpieces, and breathing handles, all essential for quantifying FeNO levels in patients. The company, which was founded in 2006 and is headquartered in Oxford, United Kingdom, was formerly known as Circassia Group Plc until its renaming to NIOX Group Plc in September 2022.
Similar medical devices company
Corfigo develops medical devices for cardiac surgery, specifically the HeartPad XLT Cryoablation System. The system utilizes liquid helium cryothermal energy to ablate diseased cardiac tissue from the heart's outer surface while protecting adjacent structures.
Similar medical devices company
ALung Technologies, Inc. is a leading provider of low-flow extracorporeal carbon dioxide removal technologies. The company was acquired by LivaNova in May 2022. It focuses on advancing respiratory care solutions.
Similar medical devices company
Clyra Medical Technologies, Inc. develops advanced wound management and irrigation products utilizing patent-protected oxidative chemistry. The company serves patients and healthcare providers by offering safe, non-toxic treatments designed to combat microorganisms and aid in wound healing without harming healthy tissue.
Similar medical devices company
Jaeger Medical is a global leader and innovator in respiratory diagnostics, delivering cutting-edge technology to healthcare professionals. Headquartered in Höchberg, Germany, the company operates as a Trudell Medical Group company.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for CSA Medical Incand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →